Jen-Chieh Lee Selected Research

Jen-Chieh Lee Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 08/2008
7	Infections 01/2023 - 01/2013
6	Sarcoma (Soft Tissue Sarcoma) 03/2024 - 04/2010
6	Diarrhea 12/2022 - 12/2014
5	Clostridium Infections 12/2022 - 12/2014
4	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2018
4	Diabetes Mellitus 01/2023 - 04/2015
4	Thalassemia 12/2015 - 02/2015
4	Intellectual Disability (Idiocy) 12/2015 - 02/2015
3	Leiomyosarcoma 12/2022 - 06/2017
3	Carcinoma (Carcinomatosis) 01/2022 - 10/2010
3	Adenocarcinoma 01/2022 - 01/2017
2	Neurofibrosarcoma (MPNST) 01/2024 - 01/2021
2	Osteomalacia 09/2023 - 03/2015
2	Communicable Diseases (Infectious Diseases) 09/2023 - 08/2017
2	Carcinogenesis 01/2023 - 10/2010
2	Liposarcoma 12/2022 - 08/2015
2	Disease Progression 08/2015 - 12/2014
2	Cytomegalovirus Infections (Inclusion Disease) 06/2015 - 12/2014
2	Bacteremia 12/2014 - 10/2013
1	Neurilemmoma (Schwannoma) 03/2024
1	Hypophosphatemia 09/2023
1	Candidemia 09/2023
1	Sepsis (Septicemia) 02/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Heart Failure 12/2022
1	Leukocytosis (Pleocytosis) 12/2022
1	Arthritis (Polyarthritis) 12/2022
1	Mpox (monkeypox) 10/2022
1	Dengue (Dengue Fever) 04/2022
1	COVID-19 02/2022
1	Aspergillosis 01/2022
1	Turcot syndrome 01/2022
1	Angiomatoid Fibrous Histiocytoma 01/2022
1	Coinfection 01/2022
1	Microsatellite Instability 01/2022
1	Keloid 01/2022
1	Myoepithelioma 01/2022
1	Toxic Megacolon 12/2021
1	Ileus 12/2021
1	Hypertension (High Blood Pressure) 04/2021

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2008
7	RNA (Ribonucleic Acid)IBA 09/2023 - 06/2017
6	Proton Pump InhibitorsIBA 01/2023 - 04/2015
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 06/2015
4	Metronidazole (Metric)FDA LinkGeneric 12/2022 - 01/2013
4	Vancomycin FDA LinkGeneric 12/2022 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2024 - 09/2012
2	pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA 09/2023 - 03/2015
2	Fibroblast Growth Factor-23IBA 09/2023 - 03/2015
2	Fibroblast Growth Factor 1 (FGF-1)IBA 09/2023 - 10/2018
2	VaccinesIBA 10/2022 - 02/2022
2	MART-1 AntigenIBA 07/2022 - 01/2019
2	AzolesIBA 01/2022 - 09/2015
2	CollagenIBA 01/2022 - 01/2020
2	NivolumabIBA 01/2022 - 01/2022
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 01/2019
2	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 08/2015
2	ChromatinIBA 11/2019 - 08/2015
2	Oncogene Proteins (Oncogene Protein)IBA 02/2017 - 08/2008
2	ParaffinIBA 01/2017 - 01/2016
2	ran-binding protein 2IBA 08/2015 - 12/2008
2	AntibodiesIBA 06/2015 - 04/2010
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 04/2015 - 12/2014
1	serpentine (alkaloid)IBA 01/2024
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2023
1	Ceftazidime (Fortum)FDA LinkGeneric 01/2023
1	Untranslated RNA (Noncoding RNA)IBA 01/2023
1	NLR ProteinsIBA 01/2023
1	Collagen Type I (Type I Collagen)IBA 01/2023
1	lenvatinibIBA 12/2022
1	eribulin FDA Link 12/2022
1	Antiviral Agents (Antivirals)IBA 10/2022
1	Immunoglobulin M (IgM)IBA 04/2022
1	AntigensIBA 04/2022
1	Viral RNAIBA 04/2022
1	nirmatrelvirIBA 02/2022
1	nirmatrelvir and ritonavir drug combinationIBA 02/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	DesminIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	MyogeninIBA 01/2022
1	CDTA (DCTA)IBA 12/2021
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2021

Therapy/Procedure

16	Therapeutics 09/2023 - 03/2012
7	Drug Therapy (Chemotherapy) 03/2024 - 01/2017
5	Length of Stay 12/2021 - 08/2015
2	Radiotherapy 01/2022 - 04/2010
2	Aftercare (After-Treatment) 09/2019 - 04/2010
2	Colectomy 01/2018 - 01/2016
1	Combined Modality Therapy 03/2024
1	Secondary Prevention 02/2022
1	Radiofrequency Ablation 01/2022
1	Thrombectomy 10/2021